The currently observed correlation between platelet-CXCL16 and CXCR6 surface expression with markers of platelet activation validates our experimental finding that ligation of CXCR6 by sCXCL16 may support a pro-thrombotic mode of action in pathophysiological settings like CAD. Here, CXCL16 is linked to coronary artery disorder.